Biogen jumps 6% ahead of a key FDA decision for its Alzheimer's drug | Markets Insider

Generating your feed, please be patient ...

Biogen jumps 6% ahead of a key FDA decision for its Alzheimer's drug | Markets Insider | Zootzle